(Total Views: 324)
Posted On: 10/30/2017 8:13:34 AM
Post# of 22813
$PTIE - Pre-NDA Meeting, November 14th for REMOXY™ ER
http://investor.paintrials.com/releasedetail....ID=1045928
Key items from this news: The REMOXY NDA remains on-track for a planned resubmission in Q1 2018.
Question for the group - do you think that after certification, the drug will be purchased by PFE for marketing?
http://investor.paintrials.com/releasedetail....ID=1045928
Key items from this news: The REMOXY NDA remains on-track for a planned resubmission in Q1 2018.
Question for the group - do you think that after certification, the drug will be purchased by PFE for marketing?
(0)
(0)Scroll down for more posts ▼
